Abstract
Blood fluidity is determined by the balance between the components of the coagulation and fibrinolytic pathways. The balance is maintained by the activators and inhibitors of the respective proenzymes and enzymes (Fig. 1). Disturbances in either of these systems lead to thrombosis or bleeding.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gjønnaes H, Fagerhol MK (1975) Studies on coagulation and fibrinolysis in pregnancy. Acta Obstet Gynecol Scand 54: 363–367
Ambrus JL, Ambrus CM, Lillie MA, Browne BJ, Hanson FW, Niswander K, Witul M, Jung DS, Bartfay-Szabo A (1976) Effects of various estrogen treatment schedules on antithrombin III levels. Commun Chemic Pathol Pharmacol 14: 543–549
Weiner CP, Brand Y (1980) Plasma antithrombin III activity in normal pregnancy. Obstet Gynecol 56: 603–610
Hellgren M, Blomäck M (1981) Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest 13: 141 – 154
Weenink GH, Treffers PE, Kahlé LH, ten Cate JW (1982) Antithrombin III in normal pregnancy. Thromb Res 26: 281–287
Villesanta U (1965) Thromboembolic disease in pregnancy. Am J Obstet Gynecol 93: 142–160
Husni EA, Pena LI, Engle-Lenhert A (1967) Thrombophlebitis in pregnancy. Am J Obstet Gynecol 97: 901–905
Aaro LA, Juergens JC (1971) Thrombophlebitis associated with pregnancy. Am J Obstet Gynecol 109: 1128–1136
Flessa HC, Glueck HI, Dritschilo A (1974) Thromboembolic disorders in pregnancy: pathophysiology, diagnosis, and treatment with emphasis on heparin. Clin Obstet Gynecol 17: 195–235
Hillesma V (1960) Occurrence and anticoagulant treatment of thromboembolism in gravidas, parturients and gynecologic patients. Acta Obstet Gynecol Scand (Suppl 2) 39: 5–76
Büller HR, Weenink AH, Treffers PE, Kahlé LH, Otten HA, ten Cate JW (1980) Severe antithrombin III deficiency in a patient with pre-eclampsia. Scand J Haematol 25: 81–86
Hellgren M, Nygards E-B, Robbe H (1982) Antithrombin III in late pregnancy. Acta Obstet Gynecol Scand 61: 187–189
Schregel W, Straub H, Wölk G, Schneider R (1984) Successful treatment of massive dissiminated intravascular coagulation in EPH gestosis with multiple organ insufficiency. Anasth Intensivther Notfallmed 19: 201–203
Goubran, F, Fareed A, Elian A, Abolouz S (1985) Antithrombin III and α 2 -macroglobulin in normal pregnancy and preeclampsia. Thromb Haemost 54: 204
Friedman KD, Borok Z, Owen J (1986) Heparin cofactor activity and antithrombin III antigen levels in preeclampsia. Thromb Res 43: 409–416
Brandt P (1981) Observations during the treatment of antithrombin III deficient women with heparin and antithrombin concentrate during pregnancy, parturation and abortion. Thromb Res 22: 15–24
Handeland GF, Abildgaard U (1985) In vivo recovery of antithrombin concentrates. Thromb Res 39: 133–138
Schoch U, Zanetti E, von Feiten A (1987) Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis. Schweiz Med Wochenschr 117: 1807–1810
De Stefano V, Leone G, de Carolis S, Ferelli R, di Donfrancesco A, Moneta E, Bizzi B (1988) Management of pregnancy in women with antithrombin III congenital defect: Report of four cases. Thromb Haemost 59: 193–196
Jürgens H, Göbel U, Bokelmann J, von Voss H, Wahn V (1979) Coagulation studies on umbilical arterial and venous blood from normal newborn babies. Eur J Pediatr 131: 199–204
Peters M, Breederveld C, Kahlé LH, ten Cate JW (1982) Rapid microanalysis of coagulation parameters by automated chromogenic substrate methods — application in neonatal patients. Thromb Res 28: 773–781
Peters M, ten Cate JW, Koo LH, Breederveld C (1984) Persistent antithrombin III deficiency: Risk factor for thromboembolic complications in neonates small for gestational age. J Pediatr 105: 310–314
Andrew M, Pars B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P (1987) Development of the human coagulation system in the full-term infant. Blood 70: 165–172
McDonald MM, Hathaway WE, Reeve EB, Leonard BD (1982) Biochemical and functional study of antithrombin III in newborn infants. Thromb Haemost 47: 56–58
Peters M, Jansen E, ten Cate J, Kahlé LH, Ockelford P, Breederveld C (1984) Neonatal antithrombin III. Br J Haematol 58: 579–587
Schmidt BK, Muraji T, Zipursky A (1986) Low antithrombin III in neonatal shock: DIC or non-specific protein depletion? Eur J Pediatr 145: 500–503
Hathaway WE, Neumann LL, Borden CA, Jacobsen LJ (1978) Immunologic studies of antithrombin III heparin cofactor in the newborn. Thromb Haemost 39: 624–630
Henriksson P, Westström G, Hedner U (1979) Umbilical artery catheterization in newborns. Acta Paediatr Scand 68: 719–723
von Kries R, Schweickert M, Gunzelmann KH, Göbel U (1984) Antithrombin III activity and concentration in healthy and ill newborns. Lab Med 7: 353–357
Peters M, ten Cate JW, Breederveld C, de Leeuw R, Emeis J, Koppe J (1984) Low antithrombin III levels in neonates with idiopathic respiratory distress syndrome: Poor prognosis. Pediatr Res 18: 273–276
Andrew M, Massicotté-Nolan P, Mitchell L, Cassidy K (1985) Dysfunctional antithrombin III in sick premature infants. Pediatr Res 19: 237–239
Schander K, Niesen K, Rehm A, Budde U, Müller N (1980) Diagnosis and therapy of a congenital antithrombin III deficiency during the neonatal period. In: Deutsch E, Lechner K (eds) Fibrinolyse, Thrombose and Haemostase. Schattauer Verlag, Stuttgart, pp 483–486
Brenner B, Fishman A, Goldsher D, Schreibman D, Tavory S (1988) Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol 27: 209–221
Markarian M (1982) Heparin resistance in newborn infants. J Pediatr 103: 175
von Kries R, Stannigel H, Göbel U (1985) Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation. Eur J Pediatr 144: 191–194
Ambrus CM, Choi TS, Cunnanan E, Eisenberg B, Staub HP, Weintraub H Q (1977) Prevention of hyaline membrane disease with plasminogen. A cooperative study. JAMA 237: 1837–1841
Peters M, ten Cate JW, Jansen E, Breederveld C (1985) Coagulation and fibrinolytic factors in the first week of life in healthy infants. J Pediatr 106: 292–295
Hadnagy J, Giertler U, Halvax L, Sulyok E, Ertl T, Csaba IF, Buchenan W (1983) The antithrombin Ill-activity in the newborn age. Dtsch Gesundh Wesen 38: 1719–1720
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Japan
About this paper
Cite this paper
Karges, H.E. (1991). AT III in Pregnancy and Newborn Infants. In: Suzuki, S., Hathaway, W.E., Bonnar, J., Sutor, A.H. (eds) Perinatal Thrombosis and Hemostasis. Springer, Tokyo. https://doi.org/10.1007/978-4-431-65871-9_6
Download citation
DOI: https://doi.org/10.1007/978-4-431-65871-9_6
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-65873-3
Online ISBN: 978-4-431-65871-9
eBook Packages: Springer Book Archive